Literature DB >> 16620795

The organoselenium compound 1,4-phenylenebis(methylene)selenocyanate inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorgenesis and enhances glutathione-related antioxidant levels in A/J mouse lung.

John P Richie1, Wayne Kleinman, Dhimant H Desai, Arunangshu Das, Shantu G Amin, John T Pinto, Karam El-Bayoumy.   

Abstract

Selenium, in the form of 1,4-phenylenebis(methylene)selenocyanate (p-XSC) but not Se-enriched yeast (Se-yeast), was highly effective at inhibiting lung tumors induced by the tobacco specific nitrosamine (TSNA) 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mice and at reducing NNK-induced DNA methylation and 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels in the lung. Our goal was to determine if p-XSC but not Se-yeast is effective at inducing levels of glutathione (GSH)-related antioxidants and reducing markers of GSH oxidation in the NNK-induced lung tumor model. In the first bioassay, 6-week-old mice were fed either control or experimental diets (containing 10 ppm as selenium from p-XSC or Se-yeast) and, beginning at 8 weeks of age, received NNK (3 micromol) by gavage once weekly for 8 weeks. After 18 weeks, p-XSC significantly reduced NNK-induced tumor burden by 74% (10.4 +/- 6.0 versus 2.7 +/- 1.5 tumors/mouse, P < 0.001) and tumor incidence from 96% to 68% (P < 0.01), whereas, Se-yeast had no effect. Lung GSH levels were unchanged by either NNK or Se-yeast, but were increased 70% in mice treated with both NNK and p-XSC (P < 0.01) and 41% in mice treated with p-XSC alone. In the second bioassay, the time course of effects of p-XSC was examined. As early as one week after initiation of p-XSC feeding lung and blood selenium levels were increased nearly six- and two-fold, respectively. Increases of 120% for GSH and 65% for Cys were observed in p-XSC groups compared to controls within one week after initiation of p-XSC feeding (P < 0.01). The levels of protein-bound:free GSH ratios and Cys ratios were significantly decreased in p-XSC-treated mice, regardless of NNK status, suggesting a decrease in the levels of oxidative stress. Altogether, these results indicate that p-XSC is a potent inducer of GSH and related thiol antioxidants in the lung leading to decreased levels of oxidative stress and suggest that p-XSC inhibits tumor formation, in part, by protecting against oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16620795     DOI: 10.1016/j.cbi.2006.03.005

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  14 in total

1.  Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.

Authors:  Tsutomu Shimada; Norie Murayama; Katsuhiro Tanaka; Shigeo Takenaka; F Peter Guengerich; Hiroshi Yamazaki; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2011-07-20       Impact factor: 3.739

2.  Age related changes in selenium and glutathione levels in different lobes of the rat prostate.

Authors:  John P Richie; Arunangshu Das; Ana M Calcagnotto; Cesar A Aliaga; Karam El-Bayoumy
Journal:  Exp Gerontol       Date:  2011-12-24       Impact factor: 4.032

3.  A functional trinucleotide repeat polymorphism in the 5'-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers.

Authors:  Sailendra N Nichenametla; Joshua E Muscat; Jason G Liao; Philip Lazarus; John P Richie
Journal:  Mol Carcinog       Date:  2012-05-18       Impact factor: 4.784

4.  Association of selenium status and blood glutathione concentrations in blacks and whites.

Authors:  John P Richie; Joshua E Muscat; Irina Ellison; Ana Calcagnotto; Wayne Kleinman; Karam El-Bayoumy
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

5.  Induction of lung glutathione and glutamylcysteine ligase by 1,4-phenylenebis(methylene)selenocyanate and its glutathione conjugate: role of nuclear factor-erythroid 2-related factor 2.

Authors:  Sans W Emmert; Karam El-Bayoumy; Arunangshu Das; Yuan-Wan Sun; Shantu Amin; Dhimant Desai; Cesar Aliaga; John P Richie
Journal:  Free Radic Biol Med       Date:  2012-04-17       Impact factor: 7.376

6.  Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence.

Authors:  Steven A Belinsky; Shuguang Leng; Guodong Wu; Cynthia L Thomas; Maria A Picchi; Sandra J Lee; Seena Aisner; Suresh Ramalingam; Fadlo R Khuri; Daniel D Karp
Journal:  Cancer Prev Res (Phila)       Date:  2017-09-13

7.  Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model.

Authors:  Christopher M Lyon; Donna M Klinge; Kieu C Do; Marcie J Grimes; Cindy L Thomas; Leah A Damiani; Thomas H March; Christine A Stidley; Steven A Belinsky
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

8.  Effects of 1,4-phenylenebis(methylene)selenocyanate on mutagenesis and p53 protein expression in the tongue of lacI rats treated with 4-nitroquinoline-N-oxide.

Authors:  Joseph Guttenplan; Kun-Ming Chen; Michael Khmelnitsky; Wieslawa Kosinska; Jeannie Hennessy; Richard Bruggeman; Dhimant Desai; Shantu Amin; Yuan-Wan Sun; Tomas E Spratt; Karam El-Bayoumy
Journal:  Mutat Res       Date:  2007-07-17       Impact factor: 2.433

Review 9.  Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers.

Authors:  Stephen S Hecht; Fekadu Kassie; Dorothy K Hatsukami
Journal:  Nat Rev Cancer       Date:  2009-07       Impact factor: 60.716

10.  NNK-Induced Lung Tumors: A Review of Animal Model.

Authors:  Hua-Chuan Zheng; Yasuo Takano
Journal:  J Oncol       Date:  2011-04-27       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.